Breast lumps screening: Difference between revisions
Jump to navigation
Jump to search
| Line 15: | Line 15: | ||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | ||
==Screening== | ==Screening== | ||
The Screening methods of breast lesions<ref name="pmid25114845">{{cite journal| author=Shah R, Rosso K, Nathanson SD| title=Pathogenesis, prevention, diagnosis and treatment of breast cancer. | journal=World J Clin Oncol | year= 2014 | volume= 5 | issue= 3 | pages= 283-98 | pmid=25114845 | doi=10.5306/wjco.v5.i3.283 | pmc=4127601 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25114845 }} </ref>: | The Screening methods of [[breast lesions]]<ref name="pmid25114845">{{cite journal| author=Shah R, Rosso K, Nathanson SD| title=Pathogenesis, prevention, diagnosis and treatment of breast cancer. | journal=World J Clin Oncol | year= 2014 | volume= 5 | issue= 3 | pages= 283-98 | pmid=25114845 | doi=10.5306/wjco.v5.i3.283 | pmc=4127601 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25114845 }} </ref>: | ||
* [[Breast examination]] | * [[Breast examination]] | ||
** Self breast examination | ** [[Self breast examination]] | ||
*** Although this is controversial, most clinicians recommend women to perform self examination monthly | *** Although this is controversial, most clinicians recommend women to perform self examination monthly | ||
**Clinical breast examination | **[[Clinical breast examination]] | ||
*** Women with age> 40 years is recommended for clinical breast examination annually | *** Women with age> 40 years is recommended for clinical breast examination annually | ||
* | * [[Breast ultrasound]] | ||
** whole breast ultrasound detects lesions in dense breast tissue which could not be diagnosed by mammography <ref name="pmid19727744">{{cite journal| author=Kelly KM, Dean J, Comulada WS, Lee SJ| title=Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. | journal=Eur Radiol | year= 2010 | volume= 20 | issue= 3 | pages= 734-42 | pmid=19727744 | doi=10.1007/s00330-009-1588-y | pmc=2822222 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19727744 }} </ref> | ** whole breast ultrasound detects lesions in dense breast tissue which could not be diagnosed by mammography <ref name="pmid19727744">{{cite journal| author=Kelly KM, Dean J, Comulada WS, Lee SJ| title=Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. | journal=Eur Radiol | year= 2010 | volume= 20 | issue= 3 | pages= 734-42 | pmid=19727744 | doi=10.1007/s00330-009-1588-y | pmc=2822222 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19727744 }} </ref> | ||
*Mammography | *[[Mammography]] | ||
**Gold standard of screening | **Gold standard of screening | ||
**Early detection of non-palpabale masses | **Early detection of non-palpabale masses | ||
| Line 29: | Line 29: | ||
**Regarding to 2013 NCCN guidelines annual screening in high risk women from age of 25 years | **Regarding to 2013 NCCN guidelines annual screening in high risk women from age of 25 years | ||
**Sensitivity of 0.33-0.39 and specificity of 0.95 | **Sensitivity of 0.33-0.39 and specificity of 0.95 | ||
*Magnetic resonance imaging (MRI) | *[[Magnetic resonance imaging (MRI)]] | ||
**Significant method for detection, assessment and management of breast cancer | **Significant method for detection, assessment and management of breast cancer | ||
**Sensitivity of 0.77-0.79 and specificity of 0.86-0.89 | **Sensitivity of 0.77-0.79 and specificity of 0.86-0.89 | ||
Revision as of 14:52, 7 December 2018
|
Breast lumps Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Breast lumps screening On the Web |
|
American Roentgen Ray Society Images of Breast lumps screening |
|
Risk calculators and risk factors for Breast lumps screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
The Screening methods of breast lesions[1]:
- Breast examination
- Self breast examination
- Although this is controversial, most clinicians recommend women to perform self examination monthly
- Clinical breast examination
- Women with age> 40 years is recommended for clinical breast examination annually
- Self breast examination
- Breast ultrasound
- whole breast ultrasound detects lesions in dense breast tissue which could not be diagnosed by mammography [2]
- Mammography
- Gold standard of screening
- Early detection of non-palpabale masses
- Regarding to 2013 NCCN guidelines annual screening in average risk women aged≥ 40 years
- Regarding to 2013 NCCN guidelines annual screening in high risk women from age of 25 years
- Sensitivity of 0.33-0.39 and specificity of 0.95
- Magnetic resonance imaging (MRI)
- Significant method for detection, assessment and management of breast cancer
- Sensitivity of 0.77-0.79 and specificity of 0.86-0.89
- Based on 2013 NCCN guidelines annual MRI for individuals with > 20% risk of developing breast cancer in lifetime starting at age of 25 years
- Beneficial modality in high risk individuals
- Valuable in individuals with equivocal results from other screening tests
- Usable for individuals with ineffective mammography results due to breast augmentation
References
- ↑ Shah R, Rosso K, Nathanson SD (2014). "Pathogenesis, prevention, diagnosis and treatment of breast cancer". World J Clin Oncol. 5 (3): 283–98. doi:10.5306/wjco.v5.i3.283. PMC 4127601. PMID 25114845.
- ↑ Kelly KM, Dean J, Comulada WS, Lee SJ (2010). "Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts". Eur Radiol. 20 (3): 734–42. doi:10.1007/s00330-009-1588-y. PMC 2822222. PMID 19727744.